MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Complete Genomics Inc., a recently launched, third-generation human genome sequencing company, today announced a collaboration with the Broad Institute of MIT and Harvard to conduct complete human genome sequencing pilot studies of two cancers — glioblastoma and melanoma.
